轉一篇文章，給白兔媽

Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.

https://khn.org/news/article/paxlovid-covid-sticker-shock-insurance/

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with covid-19 from being hospitalized or dying, and it may even reduce the risk of developing long covid. But the government plans to stop footing the bill within months, and millions of people who are at the highest risk of severe illness and are least able to afford the drug — the uninsured and seniors — may have to pay the full price.

……………

The U.S. government has so far purchased 20 million courses of Paxlovid, priced at about $530 each, a discount for buying in bulk that Pfizer CEO Albert Bourla called “really very attractive” to the federal government in a July earnings call. The drug will cost far more on the private market, although in a statement to KHN, Pfizer declined to share the planned price. The government will also stop paying for the company’s covid vaccine next year — those shots will quadruple in price, from the discount rate the government pays of $30 to about $120.

………

 

Most Purchased Covid Therapeutics Sit Unused

The U.S. bought nearly 25 million courses of Paxlovid, Lagevrio, and Evusheld. Most haven't been used yet, but the U.S. Department of Health and Human Services says that free supply will run out within months.

Paxlovid: a total of 20 million courses were purchased. 29% have been used. 15% have been delivered to pharmacies but not used. 56% are still unordered. Lagevrio: a total of 3 million courses were purchased. 27% have been used. 59% have been delivered to pharmacies but not used. 14% are still unordered. Evusheld: a total of 1.7 million courses were purchased. 38% have been used. 19% have been delivered to pharmacies but not used. 42% are still unordered.

 

Unordered

 

 

Delivered

 to pharmacies but not used

 

Used

 

Paxlovid

56%

15%

29%

20M

Lagevrio

14%

59%

27%

3M

Evusheld

42%

19%

38%

1.7M

Note: Each patient uses two courses of Evusheld. Data is as of Nov. 20, 2022.

Source: U.S. Department of Health and Human Services

 

Credit: Hannah Recht/KHN

  Embed

  Download image

 

 

 

所有跟帖： 

• 看下麵那個圖，政府采購的P藥，隻用了不到三成。錢都付過了，不用就便宜藥廠了。 -fuz- ♂ (0 bytes) () 12/23/2022 postreply 10:19:51

• 利益輸送就是這麽簡單。本來可以按需求發貨，billing 的基本合同條款。 -julie116- ♀ (0 bytes) () 12/23/2022 postreply 10:52:55

• 藥用不完也過期的。Paxloid 本來保質12月，FDA九月份延長到18個月 -GoGym- ♀ (0 bytes) () 12/23/2022 postreply 10:53:14

• 浪費的是納稅人的錢 -2008VGirl- ♀ (0 bytes) () 12/23/2022 postreply 11:21:23

• 的確浪費，但是也沒辦法。因為訂藥的時候就要說好數量，政府大概寧願多定浪費也不敢少定不夠用 -GoGym- ♀ (140 bytes) () 12/23/2022 postreply 13:48:43

• 可見美國政府已經代表人民向輝瑞支付了$106億美元購買Paxlovid，不知不覺中每個男女老幼都給輝瑞送了$32刀。 -紅燒茄子-- ♂ (0 bytes) () 12/23/2022 postreply 11:54:03

• 能不能要回$32?免費送也不要吃. -5181- ♂ (0 bytes) () 12/23/2022 postreply 12:59:36

• 研究新藥需要大筆資金的，納稅人的錢就是花的，我有輝瑞股票，還在水下呢 -hz82000- ♀ (0 bytes) () 12/23/2022 postreply 13:25:03

• 藥廠如果有回扣的話回扣一般隻給用掉的部分。沒消耗掉的拿不到回扣隻能write off -julie116- ♀ (0 bytes) () 12/23/2022 postreply 16:06:22